Aldeyra Therapeutics (ALDX) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.28
-0.21
-0.13
-0.06

Details

Expected EPS
-0.0975
Actual EPS
-0.06
Surprise EPS
0.04
Surprise Percent
+38.46%

Description

Aldeyra Therapeutics (ALDX) has reported earnings of -0.06 per share for Q2 2026.

0 Comments

Share your thoughts